Relationship Between Neutrophil-Lymphocyte Ratio Value And Severity of Mitral Stenosis Due to Rheumatic Heart Disease in Outpatients at H. Adam Malik General Hospital Medan
Authors
Abstract
Introduction: Mitral stenosis (MS) is a heart valve disease characterized by narrowing of the mitral valve, commonly caused by rheumatic heart disease. Accurate evaluation of MS severity is crucial for management, with echocardiography being the gold standard. The Neutrophil-Lymphocyte Ratio (NLR), reflecting inflammation, may correlate with MS severity. This study aims to assess the relationship between NLR values and MS severity due to rheumatic heart disease.
Method: This cross-sectional study was conducted at H. Adam Malik General Hospital Medan from January 2023 until the required sample size was achieved. Patients diagnosed with MS by echocardiography based on the American Society of Echocardiography (ASE) criteria were included. Echocardiographic parameters such as mitral valve area (MVA) and mean pressure gradient (MV mean PG), along with blood NLR values, were analyzed for associations. Statistical significance was set at P < 0.05.
Results: Significant differences in NLR values were observed between mild-to-moderate MS (1.93; 0.82–10.64) and severe MS (3.56; 1.81–13.08) (P = 0.0001, Mann-Whitney test). An NLR threshold of 2.91 predicted severe MS with 82% sensitivity and 81.8% specificity (P = 0.0001; AUC 0.856; 95% CI 0.772–0.940).
Conclusion: NLR strongly correlates with MS severity and serves as a reliable predictor for severe MS in patients with rheumatic heart disease. NLR offers a simple, cost-effective tool for assessing MS severity, complementing echocardiography in clinical practice.
Similar Articles
- Muhammad Ihsan, Nizam Zikri Akbar, Hilfan Ade Putra Lubis, Relationship Between P Wave Peak Time In Leads II And V1 With Left Ventricle Diastolic Function In Hypertension Patients , Journal of Society Medicine: Vol. 2 No. 6 (2023): June
- Mukhamad Faried, Franciscus Ginting, Tambar Kembaren, Putri Chairani Eyanoer, Factor Influencing Mortality in Moderate - Severe Covid-19 Patients In Tertiary Hospital, Indonesia , Journal of Society Medicine: Vol. 2 No. 7 (2023): July
- Al-Ma’ Arij Akbar Lubis, Cut Aryfa Andra, Andre Pasha Ketaren, Relationship between QTc interval prolongation and mortality of acute ischaemic stroke patients during treatment and three months after treatment at Adam Malik Hospital , Journal of Society Medicine: Vol. 3 No. 3 (2024): March
- M. Randy Harry, Elvita Rahmi Daulay, Radar Radius Tarigan, Correlation of Kidney Volume on CT-Scan with Kidney Function Tests in Patients with Normal Kidneys at Haji Adam Malik Hospital Medan in 2020-2021 , Journal of Society Medicine: Vol. 2 No. 4 (2023): April
- Robert Sihombing, Osmond Muftilov Pison, Management of Patients with Guillain Barre Syndrome Accompanied by Ventilator Associated Pneumonia , Journal of Society Medicine: Vol. 3 No. 5 (2024): May
- Billi, Muhammad Akbar, David Gunawan Umbas, Firdaus Hamid, Andi Kurnia Bintang, Mimi Lotisna, Estimated Glomerular Filtration Rate (eGFR) as a Predictor of 1-Month Clinical Outcome in First-Ever Acute Ischemic Stroke Patients , Journal of Society Medicine: Vol. 2 No. 12 (2023): December
- Primta Bangun, Suwarman Suwarman, Weaning Difficulty in Patient with End Stage Renal Disease Acute with Respiratory Failure due to Pulmonary Edema and Pneumonia , Journal of Society Medicine: Vol. 2 No. 2 (2023): February
- Rina Sari Mardia, Bintang YM Sinaga, Parluhutan Siagian, Ashar Taufik, Characteristics of Loss to Follow-Up Patient in Drug-Sensitive Pulmonary TB in Medan , Journal of Society Medicine: Vol. 3 No. 10 (2024): Oktober
- Maulana Taufik, Dadik Wahyu Wijaya, Andriamuri Primaputra Lubis, The Relationship Between The Characteristics of COVID-19 Patients To Predict Mortality in The COVID-19 ICU Special Care , Journal of Society Medicine: Vol. 1 No. 1 (2022): October
- Elfia Damaiyanti Br Lingga, Pandiaman Pandia, Andika Pradana, Comparison of Symptoms and Lung Function in Patients with Chronic Obstructive Pulmonary Disease (COPD) Receiving Monobronchodilators and Dual Bronchodilators , Journal of Society Medicine: Vol. 3 No. 11 (2024): November
You may also start an advanced similarity search for this article.